Predictors of mortality and end stage renal disease in Saudi patients with lupus nephritis

被引:14
作者
Al Durahim, H. [2 ]
Al Ghamdi, G. [2 ]
Al Seraya, A. [2 ]
Alkhiari, R. [2 ]
Al Sayyari, A. [1 ]
机构
[1] King Saud Bin Abdulaziz Univ Hlth Sci, Riyadh 11426, Saudi Arabia
[2] Dept Med, King Abdulaziz Med City, Saudi Arabia
关键词
lupus nephritis; Saudi Arabia; SLE; ERYTHEMATOSUS; ARABIA; CLASSIFICATION; MANIFESTATIONS; PREVALENCE; OUTCOMES; PROFILE; COHORT;
D O I
10.1177/0961203311415560
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
The purpose of this study was to investigate the presentation and factors affecting outcome over a 9-year period in 99 consecutive Saudi patients with biopsy proven lupus nephritis (LN), 35.5% of whom had nephrotic range proteinuria, 46.8% had estimated glomerular filtration rate (eGFR) <60 ml/min/1.73m(2) and 65.5% had histological class IV. The female:male ratio was 3.7:1. During the observation period, there were significant rises in eGFR (p = 0.005), C4 (p = 0.000) and significant decrease in 24-h urine protein (p = 0.028). No correlation was found between final eGFR and baseline 24-h protein, anti-DNA, C3 or C4. Female patients had a significantly higher rise in eGFR (p = 0.05). During follow-up (FU), 28.2% required dialysis. The survival rates at 5, 10 and 15 years were 92%, 77% and 77% respectively. Baseline C3 and C4 levels were significantly lower in the patients who died (p = 0.0001 and 0.02 respectively). Those who required dialysis were more likely to die (p < 0.000) (risk ratio = 4.46; 95% confidence interval 2.8-7.2). Hypertension at presentation was associated with lower baseline eGFR (p = 0.01) and final eGFR (p = 0.002) but did not affect the baseline proteinuria. Baseline eGFR of <60 ml/min/1.73m(2) at presentation was associated with lower eGFR at end of FU (p = 0.000), higher activity score (p = 0.0001) and chronicity scores (p = 0.017). Lupus (2011) 20, 1329-1335.
引用
收藏
页码:1329 / 1335
页数:7
相关论文
共 34 条
[21]   Frequency of Renal Disease in Japan: An Analysis of 2,404 Renal Biopsies at a Single Center [J].
Moriyama, Takahito ;
Suzuki, Keiko ;
Sugiura, Hidekazu ;
Itabashi, Mitsuyo ;
Tsukada, Misao ;
Takei, Takashi ;
Koike, Minako ;
Uchida, Keiko ;
Horita, Shigeru ;
Taneda, Sekiko ;
Honda, Kazuho ;
Nitta, Kosaku .
NEPHRON CLINICAL PRACTICE, 2010, 115 (03) :C227-C236
[22]   Epidemiology of systemic lupus erythematosus in Asia [J].
Osio-Salido, E. ;
Manapat-Reyes, H. .
LUPUS, 2010, 19 (12) :1365-1373
[23]   The prevalence and incidence of biopsy-proven lupus nephritis in the UK - Evidence of an ethnic gradient [J].
Patel, Mumtaz ;
Clarke, Alexandra M. ;
Bruce, Ian N. ;
Symmons, Deborah P. M. .
ARTHRITIS AND RHEUMATISM, 2006, 54 (09) :2963-2969
[24]  
POLLAK VE, 1964, J LAB CLIN MED, V63, P537
[25]  
Qari FA, 2002, SAUDI MED J, V23, P1247
[26]   LUPUS NEPHRITIS IN THAILAND - CLINICOPATHOLOGICAL FINDINGS AND OUTCOME IN 569 PATIENTS [J].
SHAYAKUL, C ;
ONGAJYOOTH, L ;
CHIRAWONG, P ;
NIMMANNIT, S ;
PARICHATIKANOND, P ;
LAOHAPAND, T ;
VASUVATTAKUL, S ;
VAREESANGTHIP, K ;
VANICHAKARN, S ;
MALASIT, P ;
NILWARANGKUR, S .
AMERICAN JOURNAL OF KIDNEY DISEASES, 1995, 26 (02) :300-307
[27]  
Skare TL, 2009, REUMATISMO, V61, P316
[28]   SPECIAL ARTICLE - THE 1982 REVISED CRITERIA FOR THE CLASSIFICATION OF SYSTEMIC LUPUS-ERYTHEMATOSUS [J].
TAN, EM ;
COHEN, AS ;
FRIES, JF ;
MASI, AT ;
MCSHANE, DJ ;
ROTHFIELD, NF ;
SCHALLER, JG ;
TALAL, N ;
WINCHESTER, RJ .
ARTHRITIS AND RHEUMATISM, 1982, 25 (11) :1271-1277
[29]  
TSAO BP, 2007, J AM SOC NEPHROL, V1, P244
[30]   Antiphospholipid Antibodies and Renal Outcomes in Patients with Lupus Nephritis [J].
Tsuruta, Yuki ;
Uchida, Keiko ;
Itabashi, Mitsuyo ;
Yumura, Wako ;
Nitta, Kosaku .
INTERNAL MEDICINE, 2009, 48 (21) :1875-1880